Dr. Alexander Kappes, MBA, serves as the Head of CMO Staff at Universitätsspital Basel, where he leverages his extensive background in healthcare management and molecular biology to drive initiatives that prioritize patient value and innovation. With a PhD in Molecular and Cell Biology, an MSc...
Dr. Alexander Kappes, MBA, serves as the Head of CMO Staff at Universitätsspital Basel, where he leverages his extensive background in healthcare management and molecular biology to drive initiatives that prioritize patient value and innovation. With a PhD in Molecular and Cell Biology, an MSc in Biology, and an MBA in General Management, Dr. Kappes is uniquely positioned to bridge the gap between scientific research and practical healthcare applications. His role involves providing strategic and scientific support to the Chief Medical Officer, focusing on enhancing quality and safety in patient care.
At Universitätsspital Basel, Dr. Kappes is at the forefront of implementing Value-Based Health Care principles, aligning with the International Consortium for Health Outcomes Measurement (ICHOM) to ensure that patient outcomes are the primary metric of success. His expertise in innovation management and translational medicine allows him to spearhead key projects that integrate cutting-edge research into clinical practice, ultimately improving patient experiences and outcomes.
Additionally, Dr. Kappes is responsible for overseeing the electronic patient record system, a critical component in modernizing healthcare delivery and ensuring seamless communication across departments. His well-established network within the University Hospital Basel and the broader healthcare community enhances his ability to foster collaborations that drive forward-thinking solutions in areas such as product lifecycle management, trauma care, and customer engagement in the pharmaceutical industry. With a passion for delivering high-quality, timely, and profitable support to clients, Dr. Kappes is committed to shaping the future of healthcare through strategic innovation and a steadfast focus on patient value.
